3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
12
Rectal Neoplasms
9
Glioblastoma
9
Esophageal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Melanoma
2
Glioma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Wilms Tumor
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
pertuzumab
1
pazopanib
1
Trastuzumab
1
Surgical Procedures, Operative
1
Sunitinib
1
Risk Assessment
1
Radiotherapy
1
Opdualag
1
Nivolumab
1
Injections, Subcutaneous
1
Bandages, Hydrocolloid
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Patient Preference
×
Surgical Procedures, Operative
×
Clear all
NCT05415215
2026-02-10
ProHer
Hoffmann-La Roche
Phase 3
Completed
346 enrolled
20 charts